Workshop Schedule
Schedule information is subject to change. Additional faculty details to be added as invitations are accepted. Last updated 2 January 2026.
|
Tuesday, 19 May 2026
|
| Time |
Session |
| 8:00 a.m. |
Course Introduction: Course Format and Expectations
Presented by Michael C. Soulen, MD, FSIR, FCIRSE
|
| 8:15 a.m. |
Anatomy of a Clinical Trial: Objectives, Outcome Measures, Hypotheses, and Common Pitfalls
Presented by Michael C. Soulen, MD, FSIR, FCIRSE
|
| 8:45 a.m. |
Review of Statistical Concepts
Presented by Nicholas J. Seewald, PhD
|
| 9:30 a.m. |
Phase I Trials: Clinical Objectives, Endpoints, Study Designs, Sample Size, and Statistical Analyses
Presented by Mark H. O'Hara, MD
|
| 10:15 a.m. |
Break
|
| 10:45 a.m. |
Phase II Trials: Clinical Objectives, Endpoints, 2-Stage Study Designs, Sample Size, and Statistical Analyses
Presented by Gregory Nadolski, MD
|
| 11:30 a.m. |
Interventional Oncology Trials: Design Complexities, and Pitfalls
Presented by Michael C. Soulen, MD, FSIR, FCIRSE
|
| 12:15 p.m. |
Lunch |
| 1:15 p.m. |
Protocol Development Group (PDG) Sessions |
| 4:45 p.m. |
Adjourn |
| 7:00 - 9:30 p.m. |
Welcome Reception
Faculty and scholars are invited to attend this welcome reception hosted in the Parlor Room at the White Dog Café, located at 3420 Sansom Street, Philadelphia, PA 19104. Connect and mingle over dinner and drinks!
|
|
Wednesday, 20 May 2026
|
| Time |
Session |
| 8:00 a.m. |
Phase III Trials: Clinical Objectives, Endpoints, Sample Size, Statistical Analyses
Presented by Amy S. Clark, MD, MSCE
|
| 8:45 a.m. |
Device Based Trials
Presented by Bruno C. Odisio, MD, PhD, FSIR, FCIRSE
|
| 9:30 a.m. |
STATS: Survival Analysis
Presented by Nicholas J. Seewald, PhD
|
| 10:00 a.m. |
Break
|
| 10:30 a.m. |
Cost Effectiveness Analysis
Presented by Resmi A. Charalel, MD, MPH
|
| 11:15 a.m. |
STATS: Study Designs and Regression Modeling Analysis
Presented by Yimei Li, PhD
|
| 12:00 p.m. |
Tips for Successful Trial Implementation
Presented by Suresh Vedantham, MD
|
| 12:30 p.m. |
Lunch |
| 1:00 p.m. |
Protocol Development Group (PDG) Sessions 2 |
| 4:00 p.m. |
Office Hours |
| 5:00 p.m. |
Adjourn |
|
Thursday, 21 May 2026
|
| Time |
Session |
| 8:00 a.m. |
Correlative Studies: Imaging and Serum/Tissue Biomarkers, Predictive vs. Prognostic Biomarkers
Presented by Jorge A. Marrero, MD, MS
|
| 8:45 a.m. |
Compliance, Ethics and Informed Consent
Presented by Vicki Sallée, PhD, MS, RD, RAC
|
| 9:30 a.m. |
FDA Regulation of Devices
Presented by Vicki Sallée, PhD, MS, RD, RAC
|
| 10:15 a.m. |
Break
|
| 10:30 a.m. |
GCP Compliance: Importance of Good Data (Coordinators/CRAs) Regulatory Adherence
Presented by Vicki Sallée, PhD, MS, RD, RAC
|
| 11:15 a.m. |
Registries and Prospective Observational Studies
Presented by Anne Marie McCarthy, ScM, PhD
|
| 11:45 a.m. |
Imaging-AI for Clinical Trial Enrichment and Evaluation and Spatially Targeted Treatment Guidance
Presented by Christos Davatzikos, PhD
|
| 12:15 p.m. |
AI Models and Tools for Clinical Trial Design, Planning, and Conduct
Presented by Qi Long, PhD
|
| 12:45 p.m. |
Leveraging the EHR for Clinical Research
Presented by Peter E. Gabriel, MD, MSE
|
| 1:00 p.m. |
Lunch |
| 1:30 p.m. |
Protocol Development Group (PDG) Sessions 3 |
| 4:00 p.m. |
Office Hours |
| 5:00 p.m. |
Adjourn |
|
Friday, 22 May 2026
|
| Time |
Session |
| 8:00 a.m. |
Combination Therapy Trials: Image-Guided and Systemic
Presented by Neil K. Taunk, MD, MSCTS
|
| 8:45 a.m. |
Incorporating Quality of Life Assessment, Financial Toxicity, and Healthcare Utilization a Clinical Research Study
Presented by Resmi A. Charalel, MD, MPH
|
| 9:30 a.m. |
STATS: Propensity Scoring and Weighted Analyses
Presented by Nicholas J. Seewald, PhD
|
| 10:15 a.m. |
Break
|
| 10:30 a.m. |
STATS: Study Designs and ROC Analysis
Presented by Nicholas J. Seewald, PhD
|
| 11:15 a.m. |
Therapeutic Trials in the Palliative Setting: Incorporating End Points Beyond Efficacy in Clinical Trials
|
| 12:30 p.m. |
How to Run a Multicenter IIT: Site Selection, Startup, and Site Budgets
Presented by Suresh Vedantham, MD
|
| 1:00 p.m. |
Lunch |
| 1:30 p.m. |
Protocol Development Group (PDG) Sessions 4
|
| 1:00 p.m. |
Lunch |
| 4:00 p.m. |
Office Hours |
| 5:00 p.m. |
Adjourn |
|
Saturday, 23 May 2026
|
| Time |
Session |
| 8:00 a.m. |
Navigating the National Clinical Trials Network
Presented by Michael C. Soulen, MD, FSIR, FCIRSE
|
| 8:30 a.m. |
How to be a Site for a Multi-Center Trial
Presented by Kathleen Thomas, MSOD
|
| 9:00 a.m. |
Funding Partnerships: Industry, Cooperative Groups, Professional Societies
Presented by Terence P. Gade, MD, PhD
|
| 9:30 a.m. |
Break |
| 10:00 a.m. |
How to Craft a Trial Budget and Smart Contracts
Presented by Gayle Meadows, MHA
|
| 10:30 a.m. |
Barriers to Accrual and How to Overcome Them
Presented by Carmen E. Guerra, MD, MSCE, FACP
|
| 11:00 a.m. |
STATS: How to Talk to a Statistician
Presented by Yimei Li, PhD and Nicholas J. Seewald, PhD
|
| 12;00 p.m. |
Concept Presentations & Lunch |
| 2:00 p.m. |
Adjourn |